We are live on ! Find out more
NBSE

NeuBase Therapeutics, Inc. Common Stock
NBSE

Delisted

NBSE was delisted on the 10th of May, 2024.

Back to rankings

64 hedge funds and large institutions have $18.4M invested in NeuBase Therapeutics, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

193% more call options, than puts

Call options by funds: $2.55M | Put options by funds: $871K

109% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 11

82% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 11

21% more funds holding

Funds holding: 53 → 64 (+11)

64% less capital invested

Capital invested by funds: $50.6M → $18.4M (-$32.1M)

Holders
64
Holders Change
+11
Holders Change %
+20.75%
% of All Funds
1.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
20
Reduced
11
Closed
11
Calls
$2.55M
Puts
$871K
Net Calls
+$1.68M
Net Calls Change
+$1.19M

Top Buyers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
+$14.7M
2
BBA
Baker Bros. Advisors
New York
+$3.06M
3
TI
Turner Investments
Pennsylvania
+$2.36M
4
KCM
Knoll Capital Management
Florida
+$1.69M
5
SFM
Sphera Funds Management
Israel
+$1.55M

Top Sellers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
-$8.62M
2
Millennium Management
Millennium Management
New York
-$5.95M
3
VM
VHCP Management
New York
-$3.98M
4
LOAMU
Lombard Odier Asset Management (USA)
New York
-$3.78M
5
KCM
Kennedy Capital Management
Missouri
-$1.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
LCM
26
Leisure Capital Management
California
$154K +$502K +152 New
Morgan Stanley
27
Morgan Stanley
New York
$150K +$459K +139 +1,544%
CCB
28
Cutter & Co Brokerage
Missouri
$125K +$281K +85 +224%
Group One Trading
29
Group One Trading
Illinois
$110K +$175K +53 +96%
New York State Common Retirement Fund
30
New York State Common Retirement Fund
New York
$104K +$337K +102 New
UBS Group
31
UBS Group
Switzerland
$100K +$36.3K +11 +13%
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$99K – – –
ARTA
33
A.R.T. Advisors
New York
$81K +$264K +80 New
Charles Schwab
34
Charles Schwab
California
$79K – – –
CCA
35
Catalyst Capital Advisors
New York
$76K +$248K +75 New
TA
36
Teachers Advisors
New York
$74K – – –
CS
37
Credit Suisse
Switzerland
$68K +$221K +67 New
BIC
38
Beach Investment Counsel
Pennsylvania
$65K -$79.2K -24 -27%
SG Americas Securities
39
SG Americas Securities
New York
$61K +$198K +60 New
Deutsche Bank
40
Deutsche Bank
Germany
$60K -$244K -74 -55%
FNBT
41
FineMark National Bank & Trust
Florida
$57K – – –
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$54K +$33K +10 +23%
WMC
43
Westwood Management Corporation
Illinois
$51K +$165K +50 New
VKH
44
Virtu KCG Holdings
New York
$49K +$158K +48 New
Bank of America
45
Bank of America
North Carolina
$47K +$149K +45 +4,500%
PPCM
46
Pillar Pacific Capital Management
California
$44K -$6.6K -2 -4%
TSS
47
Two Sigma Securities
New York
$44K +$142K +43 New
EWM
48
Edge Wealth Management
New York
$41K +$132K +40 New
Citadel Advisors
49
Citadel Advisors
Florida
$41K +$135K +41 New
NFA
50
Nationwide Fund Advisors
Ohio
$39K -$6.6K -2 -5%
1
2
3

NBSE Hedge Fund Activity: Q1 2015 in Review

64 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in NeuBase Therapeutics, Inc. Common Stock (NBSE) for Q1 2015, worth a combined $18.4M — down 64% from $50.6M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new NBSE positions and 11 closed out — a net gain of 12 holders — while 20 added to existing stakes and 11 trimmed.

The largest buyer was Broadfin Capital, opening a new position worth an estimated $14.7M. The largest seller was Visium Asset Management, exiting entirely with an estimated $8.62M sold.

  • 64 institutional investors held NeuBase Therapeutics, Inc. Common Stock (NBSE) as of Q1 2015, up from 53 in Q4 2014.
  • Funds reported $18.4M of NeuBase Therapeutics, Inc. Common Stock stock for Q1 2015, down 64% quarter-over-quarter.
  • 23 funds opened new NeuBase Therapeutics, Inc. Common Stock positions in Q1 2015 and 11 closed out, a net change of +12 holders.
  • The largest NeuBase Therapeutics, Inc. Common Stock buyer in Q1 2015 was Broadfin Capital, an estimated $14.7M added.
  • The largest NeuBase Therapeutics, Inc. Common Stock seller in Q1 2015 was Visium Asset Management, an estimated $8.62M sold.

Based on aggregated 13F filings for Q1 2015.